Melanotan II is the peptide my book calls the “Barbie Drug.” It makes you tan, it makes you thin by killing your appetite, and it makes you aroused. It sits next to PT-141 in the desire chapter, because they come from the same family. However, it was never approved, the human trials are tiny, and dermatologists keep reporting changes in the moles of the people who use it. This page covers what Melanotan II does, what the research shows, and the risks you should know before you ever touch it.
First, the basics: your skin tans because of a hormone called alpha-MSH. It tells pigment cells to make melanin, the dark pigment that protects you from the sun.
In the 1980s and 90s, researchers at the University of Arizona built synthetic versions of that hormone. Later, one of them became Melanotan II. As the Glossary puts it, it works by activating melanocortin receptors.
The catch is that Melanotan II doesn’t stay in the skin. It also hits melanocortin receptors in the brain, the same ones PT-141 targets. That’s why one injection can change your color, your hunger and your sex drive at the same time.
Pigment cells don’t only make your tan. They also form your moles, so when a drug pushes all of them at once, the moles react too.
A 2017 review collected the case reports. People using unregulated melanotans showed changes in existing moles and new, sometimes irregular moles. The review also found four cases of melanoma that came from existing moles during use or shortly after [3]. The authors are clear that nobody has proven Melanotan II caused them. Still, that’s the pattern dermatologists keep seeing.
So if you have a lot of moles, a history of melanoma, or melanoma in the family, Melanotan II is a hard no. Below are the three effects in detail, the human trials, why the book gives no dose, the better option for each goal, the full side-effect list, who should skip it and the comparison with PT-141.
The three effects in detail, the human trials, why the book gives no dose, the better option for each goal, the full side-effect list, who should skip it and the comparison with PT-141 are for members. Create your free account to keep reading.
When you create your free membership, you’ll unlock the full article and be able to continue reading.
Already a member?
This page documents Dr. Tony Huge’s research and self-experimentation. It is journalism and education, not medical advice, and it creates no doctor-patient relationship. Dr. Tony Huge holds a Juris Doctor; he is a lawyer, not a physician. Read the full Legal Disclaimer.